 | • レポートコード：QAF27762 • 出版社/出版日：QYResearch / 2021年4月6日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のレボチロキシン市場について種類別（固体スライス、注射用ボトル）、用途別（病院、薬局、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・レボチロキシン市場の概要 ・世界の主要地域別レボチロキシン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のレボチロキシン市場規模2016-2021：種類別（固体スライス、注射用ボトル） ・世界のレボチロキシン市場予測2012-2027：種類別（固体スライス、注射用ボトル） ・世界のレボチロキシン市場規模2016-2021：用途別（病院、薬局、その他） ・世界のレボチロキシン市場予測2012-2027：用途別（病院、薬局、その他） ・レボチロキシンのアメリカ市場規模と予測2016-2021 ・レボチロキシンのヨーロッパ市場規模と予測2016-2021 ・レボチロキシンの中国市場規模と予測2016-2021 ・レボチロキシンの日本市場規模と予測2016-2021 ・レボチロキシンの東南アジア市場規模と予測2016-2021 ・レボチロキシンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Abbott Ltd、Alara Pharm (Sandoz)、Forest (Actavis)、Merck Serono、Piramal Healthcare、Mylan、KING PHARMS R AND D、Jerome Stevens） ・レボチロキシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・レボチロキシンの市場動向・機会・課題 ・調査の結論 |
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body’s energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
At present, United States market is mainly occupied by own brands. The domestic enterprise technology still keeps leading level.
Market Analysis and Insights: Global Levothyroxine Market
The global Levothyroxine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Levothyroxine Scope and Market Size
The global Levothyroxine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Levothyroxine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Slice in Solid
In bottles for Injection
Segment by Application
Hospitals
Chemist’s Shops
Other
The Levothyroxine market is analysed and market size information is provided by regions (countries). Segment by Application, the Levothyroxine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
1 Levothyroxine Market Overview
1.1 Levothyroxine Product Scope
1.2 Levothyroxine Segment by Type
1.2.1 Global Levothyroxine Sales by Type (2016 & 2021 & 2027)
1.2.2 Slice in Solid
1.2.3 In bottles for Injection
1.3 Levothyroxine Segment by Application
1.3.1 Global Levothyroxine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Chemist’s Shops
1.3.4 Other
1.4 Levothyroxine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Levothyroxine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Levothyroxine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Levothyroxine Price Trends (2016-2027)
2 Levothyroxine Estimates and Forecasts by Region
2.1 Global Levothyroxine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Levothyroxine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Levothyroxine Sales Market Share by Region (2016-2021)
2.2.2 Global Levothyroxine Revenue Market Share by Region (2016-2021)
2.3 Global Levothyroxine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Levothyroxine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Levothyroxine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Levothyroxine Estimates and Projections (2016-2027)
2.4.2 Europe Levothyroxine Estimates and Projections (2016-2027)
2.4.3 China Levothyroxine Estimates and Projections (2016-2027)
2.4.4 Japan Levothyroxine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Levothyroxine Estimates and Projections (2016-2027)
2.4.6 India Levothyroxine Estimates and Projections (2016-2027)
3 Global Levothyroxine Competition Landscape by Players
3.1 Global Top Levothyroxine Players by Sales (2016-2021)
3.2 Global Top Levothyroxine Players by Revenue (2016-2021)
3.3 Global Levothyroxine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Levothyroxine as of 2020)
3.4 Global Levothyroxine Average Price by Company (2016-2021)
3.5 Manufacturers Levothyroxine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Levothyroxine Market Size by Type
4.1 Global Levothyroxine Historic Market Review by Type (2016-2021)
4.1.1 Global Levothyroxine Sales Market Share by Type (2016-2021)
4.1.2 Global Levothyroxine Revenue Market Share by Type (2016-2021)
4.1.3 Global Levothyroxine Price by Type (2016-2021)
4.2 Global Levothyroxine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Levothyroxine Sales Forecast by Type (2022-2027)
4.2.2 Global Levothyroxine Revenue Forecast by Type (2022-2027)
4.2.3 Global Levothyroxine Price Forecast by Type (2022-2027)
5 Global Levothyroxine Market Size by Application
5.1 Global Levothyroxine Historic Market Review by Application (2016-2021)
5.1.1 Global Levothyroxine Sales Market Share by Application (2016-2021)
5.1.2 Global Levothyroxine Revenue Market Share by Application (2016-2021)
5.1.3 Global Levothyroxine Price by Application (2016-2021)
5.2 Global Levothyroxine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Levothyroxine Sales Forecast by Application (2022-2027)
5.2.2 Global Levothyroxine Revenue Forecast by Application (2022-2027)
5.2.3 Global Levothyroxine Price Forecast by Application (2022-2027)
6 North America Levothyroxine Market Facts & Figures
6.1 North America Levothyroxine Sales by Company
6.1.1 North America Levothyroxine Sales by Company (2016-2021)
6.1.2 North America Levothyroxine Revenue by Company (2016-2021)
6.2 North America Levothyroxine Sales Breakdown by Type
6.2.1 North America Levothyroxine Sales Breakdown by Type (2016-2021)
6.2.2 North America Levothyroxine Sales Breakdown by Type (2022-2027)
6.3 North America Levothyroxine Sales Breakdown by Application
6.3.1 North America Levothyroxine Sales Breakdown by Application (2016-2021)
6.3.2 North America Levothyroxine Sales Breakdown by Application (2022-2027)
7 Europe Levothyroxine Market Facts & Figures
7.1 Europe Levothyroxine Sales by Company
7.1.1 Europe Levothyroxine Sales by Company (2016-2021)
7.1.2 Europe Levothyroxine Revenue by Company (2016-2021)
7.2 Europe Levothyroxine Sales Breakdown by Type
7.2.1 Europe Levothyroxine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Levothyroxine Sales Breakdown by Type (2022-2027)
7.3 Europe Levothyroxine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Levothyroxine Market Facts & Figures
8.1 China Levothyroxine Sales by Company
8.1.1 China Levothyroxine Sales by Company (2016-2021)
8.1.2 China Levothyroxine Revenue by Company (2016-2021)
8.2 China Levothyroxine Sales Breakdown by Type
8.2.1 China Levothyroxine Sales Breakdown by Type (2016-2021)
8.2.2 China Levothyroxine Sales Breakdown by Type (2022-2027)
8.3 China Levothyroxine Sales Breakdown by Application
8.3.1 China 246 Sales Breakdown by Application (2016-2021)
8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Levothyroxine Market Facts & Figures
9.1 Japan Levothyroxine Sales by Company
9.1.1 Japan Levothyroxine Sales by Company (2016-2021)
9.1.2 Japan Levothyroxine Revenue by Company (2016-2021)
9.2 Japan Levothyroxine Sales Breakdown by Type
9.2.1 Japan Levothyroxine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Levothyroxine Sales Breakdown by Type (2022-2027)
9.3 Japan Levothyroxine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Levothyroxine Market Facts & Figures
10.1 Southeast Asia Levothyroxine Sales by Company
10.1.1 Southeast Asia Levothyroxine Sales by Company (2016-2021)
10.1.2 Southeast Asia Levothyroxine Revenue by Company (2016-2021)
10.2 Southeast Asia Levothyroxine Sales Breakdown by Type
10.2.1 Southeast Asia Levothyroxine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Levothyroxine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Levothyroxine Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Levothyroxine Market Facts & Figures
11.1 India Levothyroxine Sales by Company
11.1.1 India Levothyroxine Sales by Company (2016-2021)
11.1.2 India Levothyroxine Revenue by Company (2016-2021)
11.2 India Levothyroxine Sales Breakdown by Type
11.2.1 India Levothyroxine Sales Breakdown by Type (2016-2021)
11.2.2 India Levothyroxine Sales Breakdown by Type (2022-2027)
11.3 India Levothyroxine Sales Breakdown by Application
11.3.1 India Levothyroxine Sales Breakdown by Application (2016-2021)
11.3.2 India Levothyroxine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Levothyroxine Business
12.1 Abbott Ltd
12.1.1 Abbott Ltd Corporation Information
12.1.2 Abbott Ltd Business Overview
12.1.3 Abbott Ltd Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Abbott Ltd Levothyroxine Products Offered
12.1.5 Abbott Ltd Recent Development
12.2 Alara Pharm (Sandoz)
12.2.1 Alara Pharm (Sandoz) Corporation Information
12.2.2 Alara Pharm (Sandoz) Business Overview
12.2.3 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Alara Pharm (Sandoz) Levothyroxine Products Offered
12.2.5 Alara Pharm (Sandoz) Recent Development
12.3 Forest (Actavis)
12.3.1 Forest (Actavis) Corporation Information
12.3.2 Forest (Actavis) Business Overview
12.3.3 Forest (Actavis) Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Forest (Actavis) Levothyroxine Products Offered
12.3.5 Forest (Actavis) Recent Development
12.4 Merck Serono
12.4.1 Merck Serono Corporation Information
12.4.2 Merck Serono Business Overview
12.4.3 Merck Serono Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Merck Serono Levothyroxine Products Offered
12.4.5 Merck Serono Recent Development
12.5 Piramal Healthcare
12.5.1 Piramal Healthcare Corporation Information
12.5.2 Piramal Healthcare Business Overview
12.5.3 Piramal Healthcare Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Piramal Healthcare Levothyroxine Products Offered
12.5.5 Piramal Healthcare Recent Development
12.6 Mylan
12.6.1 Mylan Corporation Information
12.6.2 Mylan Business Overview
12.6.3 Mylan Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Mylan Levothyroxine Products Offered
12.6.5 Mylan Recent Development
12.7 KING PHARMS R AND D
12.7.1 KING PHARMS R AND D Corporation Information
12.7.2 KING PHARMS R AND D Business Overview
12.7.3 KING PHARMS R AND D Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 KING PHARMS R AND D Levothyroxine Products Offered
12.7.5 KING PHARMS R AND D Recent Development
12.8 Jerome Stevens
12.8.1 Jerome Stevens Corporation Information
12.8.2 Jerome Stevens Business Overview
12.8.3 Jerome Stevens Levothyroxine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Jerome Stevens Levothyroxine Products Offered
12.8.5 Jerome Stevens Recent Development
13 Levothyroxine Manufacturing Cost Analysis
13.1 Levothyroxine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Levothyroxine
13.4 Levothyroxine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Levothyroxine Distributors List
14.3 Levothyroxine Customers
15 Market Dynamics
15.1 Levothyroxine Market Trends
15.2 Levothyroxine Drivers
15.3 Levothyroxine Market Challenges
15.4 Levothyroxine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Levothyroxine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Levothyroxine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Levothyroxine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Levothyroxine Sales (K MT) by Region (2016-2021)
Table 5. Global Levothyroxine Sales Market Share by Region (2016-2021)
Table 6. Global Levothyroxine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Levothyroxine Revenue Share by Region (2016-2021)
Table 8. Global Levothyroxine Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Levothyroxine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Levothyroxine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Levothyroxine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Levothyroxine Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Levothyroxine Sales Share by Company (2016-2021)
Table 14. Global Levothyroxine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Levothyroxine Revenue Share by Company (2016-2021)
Table 16. Global Levothyroxine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levothyroxine as of 2020)
Table 17. Global Levothyroxine Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Levothyroxine Manufacturing Sites and Area Served
Table 19. Manufacturers Levothyroxine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Levothyroxine Sales (K MT) by Type (2016-2021)
Table 22. Global Levothyroxine Sales Share by Type (2016-2021)
Table 23. Global Levothyroxine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Levothyroxine Price (USD/Unit) by Type (2016-2021)
Table 25. Global Levothyroxine Sales Share by Type (2022-2027)
Table 26. Global Levothyroxine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Levothyroxine Revenue Share by Type (2022-2027)
Table 28. Global Levothyroxine Price (USD/Unit) by Type (2022-2027)
Table 29. Global Levothyroxine Sales (K MT) by Application (2016-2021)
Table 30. Global Levothyroxine Sales Share by Application (2016-2021)
Table 31. Global Levothyroxine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Levothyroxine Price (USD/Unit) by Application (2016-2021)
Table 33. Global Levothyroxine Sales (K MT) by Application (2022-2027)
Table 34. Global Levothyroxine Sales Share by Application (2022-2027)
Table 35. Global Levothyroxine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Levothyroxine Revenue Share by Application (2022-2027)
Table 37. Global Levothyroxine Price (USD/Unit) by Application (2022-2027)
Table 38. North America Levothyroxine Sales (K MT) by Company (2016-2021)
Table 39. North America Levothyroxine Sales Market Share by Company (2016-2021)
Table 40. North America Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Levothyroxine Revenue Market Share by Company (2016-2021)
Table 42. North America Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 43. North America Levothyroxine Sales Market Share by Type (2016-2021)
Table 44. North America Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 45. North America Levothyroxine Sales Market Share by Type (2022-2027)
Table 46. North America Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 47. North America Levothyroxine Sales Market Share by Application (2016-2021)
Table 48. North America Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 49. North America Levothyroxine Sales Market Share by Application (2022-2027)
Table 50. Europe Levothyroxine Sales (K MT) by Company (2016-2021)
Table 51. Europe Levothyroxine Sales Market Share by Company (2016-2021)
Table 52. Europe Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Levothyroxine Revenue Market Share by Company (2016-2021)
Table 54. Europe Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 55. Europe Levothyroxine Sales Market Share by Type (2016-2021)
Table 56. Europe Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 57. Europe Levothyroxine Sales Market Share by Type (2022-2027)
Table 58. Europe Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 59. Europe Levothyroxine Sales Market Share by Application (2016-2021)
Table 60. Europe Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 61. Europe Levothyroxine Sales Market Share by Application (2022-2027)
Table 62. China Levothyroxine Sales (K MT) by Company (2016-2021)
Table 63. China Levothyroxine Sales Market Share by Company (2016-2021)
Table 64. China Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Levothyroxine Revenue Market Share by Company (2016-2021)
Table 66. China Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 67. China Levothyroxine Sales Market Share by Type (2016-2021)
Table 68. China Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 69. China Levothyroxine Sales Market Share by Type (2022-2027)
Table 70. China Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 71. China Levothyroxine Sales Market Share by Application (2016-2021)
Table 72. China Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 73. China Levothyroxine Sales Market Share by Application (2022-2027)
Table 74. Japan Levothyroxine Sales (K MT) by Company (2016-2021)
Table 75. Japan Levothyroxine Sales Market Share by Company (2016-2021)
Table 76. Japan Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Levothyroxine Revenue Market Share by Company (2016-2021)
Table 78. Japan Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 79. Japan Levothyroxine Sales Market Share by Type (2016-2021)
Table 80. Japan Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 81. Japan Levothyroxine Sales Market Share by Type (2022-2027)
Table 82. Japan Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 83. Japan Levothyroxine Sales Market Share by Application (2016-2021)
Table 84. Japan Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 85. Japan Levothyroxine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Levothyroxine Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Levothyroxine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Levothyroxine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Levothyroxine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Levothyroxine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Levothyroxine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Levothyroxine Sales Market Share by Application (2022-2027)
Table 98. India Levothyroxine Sales (K MT) by Company (2016-2021)
Table 99. India Levothyroxine Sales Market Share by Company (2016-2021)
Table 100. India Levothyroxine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Levothyroxine Revenue Market Share by Company (2016-2021)
Table 102. India Levothyroxine Sales by Type (2016-2021) & (K MT)
Table 103. India Levothyroxine Sales Market Share by Type (2016-2021)
Table 104. India Levothyroxine Sales by Type (2022-2027) & (K MT)
Table 105. India Levothyroxine Sales Market Share by Type (2022-2027)
Table 106. India Levothyroxine Sales by Application (2016-2021) & (K MT)
Table 107. India Levothyroxine Sales Market Share by Application (2016-2021)
Table 108. India Levothyroxine Sales by Application (2022-2027) & (K MT)
Table 109. India Levothyroxine Sales Market Share by Application (2022-2027)
Table 110. Abbott Ltd Corporation Information
Table 111. Abbott Ltd Description and Business Overview
Table 112. Abbott Ltd Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Abbott Ltd Levothyroxine Product
Table 114. Abbott Ltd Recent Development
Table 115. Alara Pharm (Sandoz) Corporation Information
Table 116. Alara Pharm (Sandoz) Description and Business Overview
Table 117. Alara Pharm (Sandoz) Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Alara Pharm (Sandoz) Levothyroxine Product
Table 119. Alara Pharm (Sandoz) Recent Development
Table 120. Forest (Actavis) Corporation Information
Table 121. Forest (Actavis) Description and Business Overview
Table 122. Forest (Actavis) Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Forest (Actavis) Levothyroxine Product
Table 124. Forest (Actavis) Recent Development
Table 125. Merck Serono Corporation Information
Table 126. Merck Serono Description and Business Overview
Table 127. Merck Serono Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Merck Serono Levothyroxine Product
Table 129. Merck Serono Recent Development
Table 130. Piramal Healthcare Corporation Information
Table 131. Piramal Healthcare Description and Business Overview
Table 132. Piramal Healthcare Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Piramal Healthcare Levothyroxine Product
Table 134. Piramal Healthcare Recent Development
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Mylan Levothyroxine Product
Table 139. Mylan Recent Development
Table 140. KING PHARMS R AND D Corporation Information
Table 141. KING PHARMS R AND D Description and Business Overview
Table 142. KING PHARMS R AND D Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. KING PHARMS R AND D Levothyroxine Product
Table 144. KING PHARMS R AND D Recent Development
Table 145. Jerome Stevens Corporation Information
Table 146. Jerome Stevens Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Jerome Stevens Description and Business Overview
Table 148. Jerome Stevens Levothyroxine Product
Table 149. Jerome Stevens Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Levothyroxine Distributors List
Table 153. Levothyroxine Customers List
Table 154. Levothyroxine Market Trends
Table 155. Levothyroxine Market Drivers
Table 156. Levothyroxine Market Challenges
Table 157. Levothyroxine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Levothyroxine Product Picture
Figure 2. Global Levothyroxine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Levothyroxine Sales Market Share by Application in 2021 & 2027
Figure 6. Hospitals Examples
Figure 7. Chemist's Shops Examples
Figure 8. Other Examples
Figure 9. Global Levothyroxine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Levothyroxine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Levothyroxine Sales (K MT) Growth Rate (2016-2027)
Figure 12. Global Levothyroxine Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Levothyroxine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Levothyroxine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Levothyroxine Sales (K MT) Growth Rate (2016-2027)
Figure 17. Europe Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Levothyroxine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Levothyroxine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Levothyroxine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Levothyroxine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Levothyroxine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Levothyroxine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Levothyroxine Players Market Share by Revenue in Levothyroxine: 2016 & 2020
Figure 28. Levothyroxine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Levothyroxine Revenue Share by Type (2016-2021)
Figure 30. Global Levothyroxine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Levothyroxine Revenue Share by Application (2016-2021)
Figure 32. Global Levothyroxine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Levothyroxine Sales Market Share by Type in 2020
Figure 34. North America Levothyroxine Sales Market Share by Application in 2020
Figure 35. Europe Levothyroxine Sales Market Share by Type in 2020
Figure 36. Europe Levothyroxine Sales Market Share by Application in 2020
Figure 37. China Levothyroxine Sales Market Share by Type in 2020
Figure 38. China Levothyroxine Sales Market Share by Application in 2020
Figure 39. Japan Levothyroxine Sales Market Share by Type in 2020
Figure 40. Japan Levothyroxine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Levothyroxine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Levothyroxine Sales Market Share by Application in 2020
Figure 43. India Levothyroxine Sales Market Share by Type in 2020
Figure 44. India Levothyroxine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Levothyroxine
Figure 47. Manufacturing Process Analysis of Levothyroxine
Figure 48. Levothyroxine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
レボチロキシンナトリウムのグローバル市場2021 Levothyroxine Sodium is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland. Abbvie was the global greatest company in Levothyroxine Sodium industry, with the revenue market Share of 23.2% in 2018, followe…- 世界のレボチロキシンナトリウム産業調査2019-2025 Levothyroxine, also known as L-thyroxine, is a manufactured form of the thyroid hormone thyroxine (T4).In 2018, the global Levothyroxine Sodium market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the …
- 世界のレボチロキシンナトリウム産業調査2019-2025 Levothyroxine, also known as L-thyroxine, is a manufactured form of the thyroid hormone thyroxine (T4).In 2018, the global Levothyroxine Sodium market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the …
- 世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hypothyroidism Drug Market The global Hypothyroidism Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 甲状腺機能低下症薬のグローバル市場調査 2019年 The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this…